The global Placenta market size is expected to reach $ 154 million by 2032, rising at a market growth of 7.5% CAGR during the forecast period (2026-2032).
Placenta is the vascular organ in most mammals that connects the fetus to the uterus of the mother. It mediates the metabolic exchanges of the developing individual through an intimate association of embryonic tissues and of specific uterine tissues, which serve the functions of respiration, nutrition, and excretion. Placentas are also used as a source of extracts for ingredients in various consumer products.
The growing interest in the therapeutic and cosmetic applications of placental products is a significant driver of the placenta market. Placenta-based products are increasingly used in skincare for their anti-aging and regenerative properties, as well as in pharmaceuticals for wound healing, tissue repair, and immune system support. The rising awareness of the potential health benefits of placental extracts, combined with advancements in biotechnology and stem cell research, is fueling demand across various industries, including cosmetics, healthcare, and nutraceuticals.
A key challenge in the placenta market is the ethical concerns and regulatory complexities surrounding the sourcing and use of human or animal placental tissues. Strict regulations govern the collection, processing, and commercialization of placenta-derived products, particularly in regions with stringent ethical standards. Additionally, ensuring the safety, quality, and consistency of these products can be difficult, as variations in sourcing and processing methods may affect efficacy. These factors can limit market growth, particularly in regions with tight regulatory oversight.
Japan is the largest consumption place, with a consumption market share nearly 36%. Following Japan, Europe is the second largest consumption place with the consumption market share of 15%. Market competition is intense. Japan Bio Products, Charites Japan, Japan Natural Laboratories, Bovogen Biologicals, Thimba Li, Agri-Lab Co-Products, etc. The top 3 vendors held 30% of the market, in terms of placenta revenue.The classification of placenta includes ovine, porcine, equine and others. Ovine accounted for a share of 45% in the global placenta market.
This report studies the global Placenta production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Placenta and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Placenta that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Placenta total production and demand, 2021-2032, (MT)
Global Placenta total production value, 2021-2032, (USD Million)
Global Placenta production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (MT), (based on production site)
Global Placenta consumption by region & country, CAGR, 2021-2032 & (MT)
U.S. VS China: Placenta domestic production, consumption, key domestic manufacturers and share
Global Placenta production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (MT)
Global Placenta production by Type, production, value, CAGR, 2021-2032, (USD Million) & (MT)
Global Placenta production by Application, production, value, CAGR, 2021-2032, (USD Million) & (MT)
This report profiles key players in the global Placenta market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Japan Bio Products, Charites Japan, Japan Natural Laboratories, Bovogen Biologicals, Thimba Li, Agri-Lab Co-Products, Yinchuan Yibaisheng, BIOFAC, Hokkaido Natural Bio Group, Shaanxi Jintai Biological Engineering, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Placenta market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (MT) and average price (US$/Kg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Placenta Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Placenta Market, Segmentation by Type:
Ovine
Porcine
Equine
Others
Global Placenta Market, Segmentation by Application:
Cosmetics
Health Tonics
Other
Companies Profiled:
Japan Bio Products
Charites Japan
Japan Natural Laboratories
Bovogen Biologicals
Thimba Li
Agri-Lab Co-Products
Yinchuan Yibaisheng
BIOFAC
Hokkaido Natural Bio Group
Shaanxi Jintai Biological Engineering
Genesis Biolaboratory
Key Questions Answered:
1. How big is the global Placenta market?
2. What is the demand of the global Placenta market?
3. What is the year over year growth of the global Placenta market?
4. What is the production and production value of the global Placenta market?
5. Who are the key producers in the global Placenta market?
6. What are the growth factors driving the market demand?
Summary:
Get latest Market Research Reports on Placenta. Industry analysis & Market Report on Placenta is a syndicated market report, published as Global Placenta Supply, Demand and Key Producers, 2026-2032. It is complete Research Study and Industry Analysis of Placenta market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.